List of Hycamtin drug patents
Hycamtin is owned by Novartis.
Hycamtin contains Topotecan Hydrochloride.
Hycamtin has a total of 1 drug patent out of which 0 drug patents have expired.
Hycamtin was authorised for market use on 11 October, 2007.
Hycamtin is available in capsule;oral dosage forms.
The generics of Hycamtin are possible to be released after 10 December, 2024.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8158645 | NOVARTIS | Compound, corresponding compositions, preparation and/or treatment methods |
Dec, 2024
(1 year, 6 months from now) | |
Drugs and Companies using TOPOTECAN HYDROCHLORIDE ingredient
Market Authorisation Date: 11 October, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
HYCAMTIN family patents
6
United States
1
Canada
1
Iceland
1
Argentina
1
Brazil
1
China
1
Australia
1
South Africa
1
Israel
1
Russia
1
Japan
1
Morocco
1
Norway
1
Taiwan
1
Korea, Republic of
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic